NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 5 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $48,000 | -96.7% | 30,494 | -95.3% | 0.00% | – |
Q1 2021 | $1,455,000 | -3.0% | 655,393 | +8.3% | 0.00% | – |
Q4 2020 | $1,500,000 | +23.0% | 605,015 | +21.9% | 0.00% | – |
Q3 2020 | $1,220,000 | -18.6% | 496,121 | +17.6% | 0.00% | – |
Q2 2020 | $1,498,000 | +4305.9% | 421,983 | +1682.2% | 0.00% | – |
Q2 2019 | $34,000 | -96.4% | 23,677 | -95.1% | 0.00% | – |
Q1 2019 | $957,000 | +56.6% | 485,584 | +4.0% | 0.00% | – |
Q4 2018 | $611,000 | -48.2% | 466,747 | -2.8% | 0.00% | – |
Q3 2018 | $1,180,000 | -26.2% | 480,363 | +0.9% | 0.00% | – |
Q2 2018 | $1,599,000 | -17.0% | 476,234 | +4.5% | 0.00% | – |
Q1 2018 | $1,927,000 | +53.1% | 455,613 | +19.4% | 0.00% | – |
Q4 2017 | $1,259,000 | +1.0% | 381,582 | +17.1% | 0.00% | – |
Q3 2017 | $1,246,000 | -5.8% | 325,887 | +8.3% | 0.00% | – |
Q2 2017 | $1,323,000 | – | 300,863 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEDBUSH SECURITIES INC | 277,177 | $915,000 | 0.11% |
WEBSTER BANK, N. A. | 50,000 | $165,000 | 0.02% |
Brown Advisory Securities, LLC | 28,000 | $92,000 | 0.02% |
SIMPLEX TRADING, LLC | 50,804 | $167,000 | 0.01% |
GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $83,000 | 0.00% |
GROUP ONE TRADING, L.P. | 89,372 | $295,000 | 0.00% |
Squarepoint Ops LLC | 10,194 | $34,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,851 | $6,000 | 0.00% |
WOLVERINE TRADING, LLC | 58,500 | $193,000 | 0.00% |
WOLVERINE TRADING, LLC | 61,690 | $204,000 | 0.00% |